ASSOCIATION OF HISTOLOGIC-ENDOSCOPIC RESPONSE AND LONG-TERM CLINICAL OUTCOMES: RESULTS FROM PHASE 2 MIRIKIZUMAB TRIAL IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE CROHN’S DISEASE

Vipul Jairath  1     Marijana Protic  2     Walter Reinisch  3     Gert De Hertogh  4     Noam Harpaz  5     Rish Pai  6     Zhantao Lin  6     Rebecca Hozak  6     Hilde Carlier  6     Fernando Magro  7    
1 Western University, London, Canada
2 Eli Lilly and Company, Indianapolis, United States
3 Medical University of Vienna, Wien, Austria
4 University Hospital Leuven, Leuven, Belgium
5 Icahn School of Medicine at Mount Sinai, New York, United States
6 Mayo Clinic, Scottsdale, United States
7 Centro Hospitalar São João, Porto, Portugal

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing